Coldstream Capital Management’s Sanofi SNY Stock Holding History

Coldstream Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$329K	Sell	6,821 -3,310	-33%	-$154K	﹤0.01%	888
2025 Q4	$491K	Buy	10,131 +978	+11%	+$48.5K	0.01%	735
2025 Q3	$432K	Sell	9,153 -4,006	-30%	-$193K	0.01%	802
2025 Q2	$636K	Buy	13,159 +6,210	+89%	+$317K	0.01%	559
2025 Q1	$385K	Buy	6,949 +1,430	+26%	+$77.4K	0.01%	724
2024 Q4	$266K	Sell	5,519 -562	-9%	-$28.6K	0.01%	883
2024 Q3	$350K	Buy	6,081 +866	+17%	+$46.8K	0.01%	761
2024 Q2	$253K	Sell	5,215 -88	-2%	-$4.25K	0.01%	832
2024 Q1	$258K	Buy	+5,303	New	+$259K	0.01%	832

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Coldstream Capital Management's SNY Position: Q1 2026 in Review

Coldstream Capital Management reduced its Sanofi (SNY) stake by 33% in Q1 2026, selling an estimated $154K and leaving 6,821 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

Coldstream Capital Management first reported a position in SNY in Q1 2024 and has held it in 9 quarters since. The position peaked at $636K in Q2 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Coldstream Capital Management held 6,821 shares of Sanofi worth $329K as of Q1 2026.
Coldstream Capital Management sold 3,310 Sanofi shares in Q1 2026, an estimated $154K.
Sanofi made up ﹤0.01% of Coldstream Capital Management's portfolio in Q1 2026, its #888 holding.
Coldstream Capital Management first reported a position in Sanofi in Q1 2024 and has held it in 9 quarters since.
Coldstream Capital Management's Sanofi position peaked at $636K in Q2 2025.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.